Need Help? Call 1­-866-­796-­7386
« back to stock screener

  TARO stock: Taro Pharmaceutical Industries

Current Rating
Buy

Previous Rating

Hold/Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$113.19
Market Cap
4.4B
Sector
Health Care
Div. Growth
-
P/E
11.0
P/B
2.05
P/S
5.44
Dividend %
-
P/CF
-
P/FCF
11.1
Op. Cash Flow
454.2K
FCF
9.7
Op. Margin
55.80%
Net Margin
49.70%
ROE
19.80%
ROI
19.90%
ROA
17.70%
EPS Growth
-23.50%
Current Ratio
9.5
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Digirad Corporation (DRAD) $2.45 - 11.00% 40M Strong Buy
Brainstorm Cell Therapeutics I (BCLI) $4.13 - - 82.2M Strong Buy
Molecular Templates Inc (MTEM) $8.00 - - 46.4M Strong Buy
Lannett Company, Inc. (LCI) $23.95 - - 842.6M Strong Buy
Biostar Pharmaceuticals Inc (BSPM) $1.96 - - 4.3M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More